World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
60214
World Ranking
7501
National Ranking
3919

Overview

Paul W. Noble is affiliated with Cedars-Sinai Medical Center in the United States. Their research primarily focuses on the field of Medicine, with a strong emphasis on Pulmonary and Respiratory Medicine. Additional subfields of interest include Surgery, Molecular Biology, Infectious Diseases, and Oncology.

The scientist's main research topics include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Neonatal Respiratory Health Research
  • Medical Imaging and Pathology Studies
  • Congenital Diaphragmatic Hernia Studies
  • COVID-19 Clinical Research Studies
  • Extracellular vesicles in disease
  • Transplantation: Methods and Outcomes

Paul W. Noble has published extensively, contributing to multiple articles in notable venues. Frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • American Journal of Respiratory Cell and Molecular Biology
  • European Respiratory Journal
  • UNC Libraries

Recent papers by this scientist include:

  • "Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis," 2020, American Journal of Respiratory and Critical Care Medicine
  • "Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis," 2020, International Journal of Molecular Sciences
  • "Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022," 2022, MMWR Morbidity and Mortality Weekly Report
  • "Pre-existing traits associated with Covid-19 illness severity," 2020, PLoS ONE
  • "Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs," 2020, American Journal of Respiratory and Critical Care Medicine

The scientist has collaborated frequently with several co-authors, including:

  • Dianhua Jiang
  • Barry R. Stripp
  • Jiurong Liang
  • Xue Liu
  • Changfu Yao

Best Publications

  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

    William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

    Talmadge E. King;Williamson Z. Bradford;Socorro Castro-Bernardini;Elizabeth A. Fagan

  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

    Paul W Noble;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation

    R. J. M. Snijders;P. Noble;N. Sebire;A. Souka

  • Leptin regulates proinflammatory immune responses

    S. Loffreda;S. Q. Yang;H. Z. Lin;C. L. Karp

  • Regulation of lung injury and repair by Toll-like receptors and hyaluronan.

    Dianhua Jiang;Jiurong Liang;Juan Fan;Shuang Yu

  • Type 2 alveolar cells are stem cells in adult lung

    Christina E. Barkauskas;Michael J. Cronce;Craig R. Rackley;Emily J. Bowie

  • Signaling properties of hyaluronan receptors.

    Eva A. Turley;Paul W. Noble;Lilly Y.W. Bourguignon

  • Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

    Luca Richeldi;Ulrich Costabel;Moises Selman;Dong Soon Kim

  • Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1

    Chun Geun Lee;Robert J. Homer;Zhou Zhu;Sophie Lanone

  • Hyaluronan as an Immune Regulator in Human Diseases

    Dianhua Jiang;Jiurong Liang;Paul W. Noble

  • Hyaluronan in Tissue Injury and Repair

    Dianhua Jiang;Jiurong Liang;Paul W. Noble

  • Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition

    Jason R. Rock;Christina E. Barkauskas;Michael J. Cronce;Yan Xue

  • Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.

    Charlotte M. McKee;Margaret B. Penno;Mary Cowman;Marie D. Burdick

  • A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis

    Ganesh Raghu;Kevin K. Brown;Williamson Z. Bradford;Karen Starko

  • Resolution of Lung Inflammation by CD44

    Priit Teder;R. William Vandivier;Dianhua Jiang;Jiurong Liang

  • CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.

    Xuerong Shi;Lin Leng;Tian Wang;Wenkui Wang

  • Hyaluronan and its catabolic products in tissue injury and repair.

    Paul W Noble

  • The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis

    Fernando J. Martinez;Sharon Safrin;Derek Weycker;Karen M. Starko

Frequent Co-Authors

Ulrich Costabel
Ulrich Costabel University of Duisburg-Essen
Roland M. du Bois
Roland M. du Bois Imperial College London
Talmadge E. King
Talmadge E. King University of California, San Francisco
Dominique Valeyre
Dominique Valeyre Université Paris Cité
Steven A. Sahn
Steven A. Sahn Medical University of South Carolina
Barry R. Stripp
Barry R. Stripp Cedars-Sinai Medical Center
Ganesh Raghu
Ganesh Raghu University of Washington
Robert J. Homer
Robert J. Homer Yale University
Kevin K. Brown
Kevin K. Brown National Jewish Health
Cory M. Hogaboam
Cory M. Hogaboam Cedars-Sinai Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career doesn't always require the traditional path of attending medical school. There are many alternative healthcare degrees and certifications available online, catering to a variety of interests and backgrounds.

For those interested in patient care, some easy nursing programs to get into provide flexible entry requirements and faster ways to start your nursing career. Some schools even offer options for those looking for nursing schools that don't require teas or hesi, making the admissions process less stressful.

If you’re more interested in the administrative side of healthcare, earning a degree from one of the health administration degree programs can open doors to leadership roles in clinics, hospitals, or insurance companies.

Those looking for quick entry into the medical field might consider online medical billing and coding schools that accept fafsa. These programs often offer financial aid, making them accessible for students seeking affordability and job stability.

Best Scientists Citing Paul W. Noble

Trending Scientists

Recently Published Articles